Sinopharm Group Co. Ltd. (1099.HK)
HKD 17.96
(-2.07%)
HKD 17.96
(-2.07%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 | 26.23 Billion CNY | 8.29% |
| 2022 | 24.22 Billion CNY | 7.15% |
| 2021 | 22.6 Billion CNY | 10.08% |
| 2020 | 20.53 Billion CNY | 7.94% |
| 2019 | 19.02 Billion CNY | 22.97% |
| 2018 | 15.47 Billion CNY | 38.52% |
| 2017 | 11.17 Billion CNY | 6.82% |
| 2016 | 10.45 Billion CNY | 10.81% |
| 2015 | 9.43 Billion CNY | 12.33% |
| 2014 | 8.4 Billion CNY | 16.07% |
| 2013 | 7.23 Billion CNY | 19.06% |
| 2012 | 6.07 Billion CNY | 28.84% |
| 2011 | 4.71 Billion CNY | 37.68% |
| 2010 | 3.42 Billion CNY | 53.38% |
| 2009 | 2.23 Billion CNY | 19.94% |
| 2008 | 1.86 Billion CNY | 5.79% |
| 2007 | 1.76 Billion CNY | 16.67% |
| 2006 | 1.5 Billion CNY | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q1 | - CNY | -100.0% |
| 2023 Q4 | 13.73 Billion CNY | -96.71% |
| 2023 FY | 26.23 Billion CNY | 8.29% |
| 2023 Q3 | 417.63 Billion CNY | 3088.05% |
| 2023 Q2 | 13.09 Billion CNY | 0.0% |
| 2022 Q4 | -366.01 Billion CNY | -196.56% |
| 2022 FY | 24.22 Billion CNY | 7.15% |
| 2022 Q2 | 12.17 Billion CNY | 0.0% |
| 2022 Q3 | 379.03 Billion CNY | 3013.19% |
| 2021 FY | 22.6 Billion CNY | 10.08% |
| 2021 Q4 | 12.49 Billion CNY | 0.0% |
| 2021 Q2 | 11.39 Billion CNY | 0.0% |
| 2020 FY | 20.53 Billion CNY | 7.94% |
| 2020 Q2 | 9.69 Billion CNY | 0.0% |
| 2020 Q4 | 12.32 Billion CNY | 0.0% |
| 2019 Q4 | 11.14 Billion CNY | 0.0% |
| 2019 Q2 | 9.71 Billion CNY | 0.0% |
| 2019 FY | 19.02 Billion CNY | 22.97% |
| 2018 Q2 | 7.1 Billion CNY | 0.0% |
| 2018 FY | 15.47 Billion CNY | 38.52% |
| 2018 Q4 | 9.37 Billion CNY | 0.0% |
| 2017 Q1 | -25.03 Million CNY | -100.46% |
| 2017 Q4 | 7.55 Billion CNY | 0.0% |
| 2017 FY | 11.17 Billion CNY | 6.82% |
| 2017 Q2 | 4.86 Billion CNY | 19543.23% |
| 2016 Q4 | 5.41 Billion CNY | 0.0% |
| 2016 FY | 10.45 Billion CNY | 10.81% |
| 2016 Q2 | 4.61 Billion CNY | 0.0% |
| 2015 FY | 9.43 Billion CNY | 12.33% |
| 2015 Q4 | 5 Billion CNY | 0.0% |
| 2015 Q2 | 4.43 Billion CNY | 0.0% |
| 2014 FY | 8.4 Billion CNY | 16.07% |
| 2014 Q2 | 3.92 Billion CNY | 0.0% |
| 2014 Q4 | 4.47 Billion CNY | 0.0% |
| 2013 Q2 | 3.31 Billion CNY | 0.0% |
| 2013 Q4 | 3.92 Billion CNY | 0.0% |
| 2013 FY | 7.23 Billion CNY | 19.06% |
| 2012 Q4 | -6.8 Million CNY | -343.71% |
| 2012 FY | 6.07 Billion CNY | 28.84% |
| 2012 Q3 | -1.53 Million CNY | 0.0% |
| 2012 Q2 | -1.53 Million CNY | 0.0% |
| 2012 Q1 | -1.53 Million CNY | 0.0% |
| 2011 Q4 | -1.53 Million CNY | 96.37% |
| 2011 Q3 | -42.23 Million CNY | 0.0% |
| 2011 Q1 | -42.23 Million CNY | 0.0% |
| 2011 Q2 | -42.23 Million CNY | 0.0% |
| 2011 FY | 4.71 Billion CNY | 37.68% |
| 2010 Q2 | -19.34 Million CNY | 0.0% |
| 2010 FY | 3.42 Billion CNY | 53.38% |
| 2010 Q1 | -19.34 Million CNY | 0.0% |
| 2010 Q3 | -19.34 Million CNY | 0.0% |
| 2010 Q4 | -42.23 Million CNY | -118.35% |
| 2009 Q4 | -19.34 Million CNY | -46.36% |
| 2009 FY | 2.23 Billion CNY | 19.94% |
| 2009 Q2 | -13.21 Million CNY | 0.0% |
| 2009 Q3 | -13.21 Million CNY | 0.0% |
| 2009 Q1 | -13.21 Million CNY | 0.0% |
| 2008 FY | 1.86 Billion CNY | 5.79% |
| 2008 Q4 | -13.21 Million CNY | 24.4% |
| 2008 Q3 | -17.48 Million CNY | 0.0% |
| 2008 Q2 | -17.48 Million CNY | 0.0% |
| 2008 Q1 | -17.48 Million CNY | 0.0% |
| 2007 Q2 | -5.99 Million CNY | 0.0% |
| 2007 Q3 | -5.99 Million CNY | 0.0% |
| 2007 Q4 | -17.48 Million CNY | -191.42% |
| 2007 FY | 1.76 Billion CNY | 16.67% |
| 2007 Q1 | -5.99 Million CNY | 0.0% |
| 2006 Q3 | -4.31 Million CNY | 0.0% |
| 2006 Q4 | -5.99 Million CNY | -38.92% |
| 2006 FY | 1.5 Billion CNY | 0.0% |
| 2006 Q1 | -4.31 Million CNY | 0.0% |
| 2006 Q2 | -4.31 Million CNY | 0.0% |
| 2005 Q4 | -4.31 Million CNY | 0.0% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| Wanjia Group Holdings Limited | 70.14 Million HKD | -37302.297% |
| China Health Group Limited | 56.52 Million HKD | -46312.594% |
| Tai United Holdings Limited | 387.97 Million HKD | -6662.031% |